Cyclohexanone Exposure in Children on Extracorporeal Membrane Oxygenation Support.

Area of Science:

• Biochemistry
• Pediatric Critical Care
• Medical Technology

Background:

• Extracorporeal membrane oxygenation (ECMO) is a life-support technology for critically ill children.
• Identifying biomarkers to predict outcomes in pediatric ECMO patients is crucial for optimizing care.

Purpose of the Study:

• To investigate the association between plasma cyclohexanone and its metabolites with clinical outcomes in pediatric ECMO patients.
• To determine if specific metabolite concentrations can predict unfavorable outcomes.

Main Methods:

• Secondary analysis of a prospective observational study involving 90 children on ECMO.
• Measurement of plasma cyclohexanone and metabolites on the first and last days of ECMO support.
• Definition of unfavorable outcome as in-hospital death or significant functional decline post-discharge.

Main Results:

• Cyclohexanediol, a cyclohexanone metabolite, was detected in all samples.
• Higher initial cyclohexanediol concentrations on the first ECMO day were significantly associated with unfavorable outcomes (p = 0.04).
• A twofold increase in initial cyclohexanediol levels correlated with a 1.24-fold increased risk of unfavorable outcomes.

Conclusions:

• Plasma cyclohexanediol concentrations on the first ECMO day may serve as a predictive biomarker for clinical outcomes in pediatric ECMO patients.
• Further research is warranted to explore the clinical utility of cyclohexanediol in managing pediatric ECMO patients.